Fig. 1: Cohort curation and summary.
From: Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
a A systematic literature review was performed to identify studies reporting clinically annotated samples and/or molecularly profiled cohorts of adult AML. 12 cohorts met inclusion criteria and were curated for mutations, drug screening results, clinical features, and survival outcomes. These studies were then aggregated into a uniformly annotated database with an admixture of overlapping data types available for analysis. b Oncoprint for the most frequently mutated genes in our cohort. Each column is an individual sample (n = 2914) and the color of the vertical line represents the type of mutation reported. Sex, cohort, ELN 2017 risk group, subset, and survival information is indicated on the bottom of the plot. Source data are provided as a Source Data file.
